Erschienen in:
01.05.2014 | Original Research
Chronic Granulomatous Disease in Morocco: Genetic, Immunological, and Clinical Features of 12 Patients from 10 Kindreds
verfasst von:
Laila Ait Baba, Fatima Ailal, Naima El Hafidi, Marjorie Hubeau, Fabienne Jabot-Hanin, Noufissa Benajiba, Zahra Aadam, Francesca Conti, Caroline Deswarte, Leila Jeddane, Ayoub Aglaguel, Ouafaa El Maataoui, Ahmed Tissent, Chafiq Mahraoui, Jilali Najib, Ruben Martinez-Barricarte, Laurent Abel, Norddine Habti, Rachid Saile, Jean-Laurent Casanova, Jacinta Bustamante, Hanane Salih Alj, Ahmed Aziz Bousfiha
Erschienen in:
Journal of Clinical Immunology
|
Ausgabe 4/2014
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Chronic granulomatous disease (CGD) is characterized by an inability of phagocytes to produce reactive oxygen species (ROS), which are required to kill some microorganisms. CGD patients are known to suffer from recurrent bacterial and/or fungal infections from the first year of life onwards. From 2009 to 2013, 12 cases of CGD were diagnosed in Morocco. We describe here these Moroccan cases of CGD.
Methods
We investigated the genetic, immunological and clinical features of 12 Moroccan patients with CGD from 10 unrelated kindreds.
Results
All patients were children suffering from recurrent bacterial and/or fungal infections. All cases displayed impaired NADPH oxidase activity in nitroblue tetrazolium (NBT), dihydrorhodamine (DHR) or 2′,7′ dichlorofluorescein diacetate (DCFH-DA) assays. Mutation analysis revealed the presence of four different mutations of CYBB in four kindreds, a recurrent mutation of NCF1 in three kindreds, and a new mutation of NCF2 in three patients from a single kindred. A large deletion of CYBB gene has detected in a patient. The causal mutation in the remaining one kindred was not identified.
Conclusion
The clinical features and infectious agents found in these patients were similar to those in CGD patients from elsewhere. The results of mutation analysis differed between kindreds, revealing a high level of genetic and allelic heterogeneity among Moroccan CGD patients. The small number of patients in our cohort probably reflects a lack of awareness of physicians. Further studies on a large cohort are required to determine the incidence and prevalence of the disease, and to improve the description of the genetic and clinical features of CGD patients in Morocco.